{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:21:37Z","timestamp":1791429697904,"version":"4.3.3"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior \u2013 Brasil","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2024\/00951-0"],"award-info":[{"award-number":["2024\/00951-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2024\/00260-7"],"award-info":[{"award-number":["2024\/00260-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2024\/18204-6"],"award-info":[{"award-number":["2024\/18204-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310849\/2023-3"],"award-info":[{"award-number":["310849\/2023-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioMed Eng OnLine"],"DOI":"10.1186\/s12938-025-01476-4","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:05:40Z","timestamp":1762430740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["3D bioprinted melanoma models: a novel paradigm for the assessment of anticancer strategies combining PDT and drug delivery systems"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2844-2604","authenticated-orcid":false,"given":"St\u00e9phanie Rochetti","family":"do Amaral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar Plamenov","family":"Atanasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora Caroline Marques","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Freitas","family":"de Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus Liberato","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam Michael","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6293-4157","authenticated-orcid":false,"given":"Fernando Lucas","family":"Primo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"1476_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05661","author":"V Gray-Schopfer","year":"2007","unstructured":"Gray-Schopfer V, Wellbrock C, Marais R, Nature Publishing Group. Melanoma biology and new targeted therapy. Nature. 2007. https:\/\/doi.org\/10.1038\/nature05661.","journal-title":"Nature"},{"issue":"6","key":"1476_CR2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s40257-023-00795-3","volume":"24","author":"J Huang","year":"2023","unstructured":"Huang J, et al. Global incidence, mortality, risk factors and trends of melanoma: a systematic analysis of registries. Am J Clin Dermatol. 2023;24(6):965\u201375. https:\/\/doi.org\/10.1007\/s40257-023-00795-3.","journal-title":"Am J Clin Dermatol"},{"key":"1476_CR3","doi-asserted-by":"publisher","DOI":"10.1039\/c7pp00411g","author":"AE Cust","year":"2018","unstructured":"Cust AE, Mishra K, Berwick M. Melanoma-role of the environment and genetics. Photochem Photobiol Sci. 2018. https:\/\/doi.org\/10.1039\/c7pp00411g.","journal-title":"Photochem Photobiol Sci"},{"key":"1476_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105384","author":"J T\u00edm\u00e1r","year":"2022","unstructured":"T\u00edm\u00e1r J, Lad\u00e1nyi A. Molecular pathology of skin melanoma: epidemiology, differential diagnostics, prognosis and therapy prediction. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23105384.","journal-title":"Int J Mol Sci"},{"key":"1476_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112869","author":"Y Lin","year":"2022","unstructured":"Lin Y, Jiang L, He Q, Yuan M, Cao J. Progress and perspective of organoid technology in cancer-related translational medicine. Biomed Pharmacother. 2022. https:\/\/doi.org\/10.1016\/j.biopha.2022.112869.","journal-title":"Biomed Pharmacother"},{"key":"1476_CR6","volume-title":"Melanoma","year":"2021","unstructured":"Hargadon KM, editor. Melanoma. New York: Springer; 2021."},{"key":"1476_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000932","author":"D Barozzi","year":"2023","unstructured":"Barozzi D, Scielzo C, Wolters Kluwer Health. Emerging strategies in 3D culture models for hematological cancers. HemaSphere. 2023. https:\/\/doi.org\/10.1097\/HS9.0000000000000932.","journal-title":"HemaSphere"},{"issue":"1","key":"1476_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bulcan.2021.09.019","volume":"109","author":"G Alzeeb","year":"2022","unstructured":"Alzeeb G, Corcos L, Le Jossic-Corcos C. Des sph\u00e9ro\u00efdes aux organo\u00efdes\u202f: mod\u00e8les de cancers solides pour la d\u00e9couverte de mol\u00e9cules anticanc\u00e9reuses. Bull Cancer. 2022;109(1):49\u201357. https:\/\/doi.org\/10.1016\/j.bulcan.2021.09.019.","journal-title":"Bull Cancer"},{"key":"1476_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2023.05.012","author":"HHN Yan","year":"2023","unstructured":"Yan HHN, Chan AS, Lai FPL, Leung SY. Organoid cultures for cancer modeling. Cell Stem Cell. 2023. https:\/\/doi.org\/10.1016\/j.stem.2023.05.012.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1476_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02021-y","volume":"21","author":"F Vakhshiteh","year":"2023","unstructured":"Vakhshiteh F, et al. Heterotypic tumor spheroids: a platform for nanomedicine evaluation. J Nanobiotechnology. 2023;21(1):249. https:\/\/doi.org\/10.1186\/s12951-023-02021-y.","journal-title":"J Nanobiotechnology"},{"key":"1476_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01024-9","author":"XY Tang","year":"2022","unstructured":"Tang XY, et al. Human organoids in basic research and clinical applications. Signal Transduct Target Ther. 2022. https:\/\/doi.org\/10.1038\/s41392-022-01024-9.","journal-title":"Signal Transduct Target Ther"},{"key":"1476_CR12","unstructured":"G. Alzeeb and B. Pharma. D\u00e9veloppement d\u2019un mod\u00e8le cellulaire flexible tridimensionnel\u202f: un focus sur le cancer gastrique. 2022. https:\/\/www.researchgate.net\/publication\/365439364"},{"key":"1476_CR13","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/ad651f","author":"M de Villiers","year":"2024","unstructured":"de Villiers M, Kotze AF, du Plessis LH. Pneumatic extrusion bioprinting-based high throughput fabrication of a melanoma 3D cell culture model for anti-cancer drug screening. Biomed Mater. 2024. https:\/\/doi.org\/10.1088\/1748-605X\/ad651f.","journal-title":"Biomed Mater"},{"issue":"4","key":"1476_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41551-019-0471-7","volume":"4","author":"SV Murphy","year":"2019","unstructured":"Murphy SV, De Coppi P, Atala A. Opportunities and challenges of translational 3D bioprinting. Nat Biomed Eng. 2019;4(4):370\u201380. https:\/\/doi.org\/10.1038\/s41551-019-0471-7.","journal-title":"Nat Biomed Eng"},{"issue":"10","key":"1476_CR15","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1002\/bit.28429","volume":"120","author":"S Sang","year":"2023","unstructured":"Sang S, et al. 3D printing to construct in vitro multicellular models of melanoma. Biotechnol Bioeng. 2023;120(10):2853\u201364. https:\/\/doi.org\/10.1002\/bit.28429.","journal-title":"Biotechnol Bioeng"},{"key":"1476_CR16","doi-asserted-by":"publisher","DOI":"10.1039\/d2bm02060b","author":"R Sharma","year":"2023","unstructured":"Sharma R, et al. 3D bioprinting complex models of cancer. Biomater Sci. 2023. https:\/\/doi.org\/10.1039\/d2bm02060b.","journal-title":"Biomater Sci"},{"issue":"19","key":"1476_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194652","volume":"14","author":"J Lopes","year":"2022","unstructured":"Lopes J, Rodrigues CMP, Gaspar MM, Reis CP. Melanoma management: from epidemiology to treatment and latest advances. Cancers. 2022;14(19):4652. https:\/\/doi.org\/10.3390\/cancers14194652.","journal-title":"Cancers"},{"key":"1476_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2024.04.032","author":"C Qu\u00edlez","year":"2024","unstructured":"Qu\u00edlez C, et al. Targeting the complexity of in vitro skin models: a review of cutting-edge developments. J Invest Dermatol. 2024. https:\/\/doi.org\/10.1016\/j.jid.2024.04.032.","journal-title":"J Invest Dermatol"},{"key":"1476_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-801654-1.00001-2","author":"J Fenner","year":"2016","unstructured":"Fenner J, Clark RAF. Anatomy, physiology, histology, and immunohistochemistry of human skin. Skin Tissue Eng Regenerative Med. 2016. https:\/\/doi.org\/10.1016\/B978-0-12-801654-1.00001-2.","journal-title":"Skin Tissue Eng Regenerative Med"},{"issue":"3","key":"1476_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058709","volume":"8","author":"M Banas","year":"2013","unstructured":"Banas M, et al. Chemerin is an antimicrobial agent in human epidermis. PLoS ONE. 2013;8(3):e58709. https:\/\/doi.org\/10.1371\/journal.pone.0058709.","journal-title":"PLoS ONE"},{"issue":"6","key":"1476_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063035","volume":"22","author":"K-M Lim","year":"2021","unstructured":"Lim K-M. Skin epidermis and barrier function. Int J Mol Sci. 2021;22(6):3035. https:\/\/doi.org\/10.3390\/ijms22063035.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1476_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mpsur.2021.11.005","volume":"40","author":"G McKnight","year":"2022","unstructured":"McKnight G, Shah J, Hargest R. Physiology of the skin. Surg Infect. 2022;40(1):8\u201312. https:\/\/doi.org\/10.1016\/j.mpsur.2021.11.005.","journal-title":"Surg Infect"},{"key":"1476_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpmed.2025.04.013","author":"JA McGrath","year":"2025","unstructured":"McGrath JA. Structure and function of skin, hair and nails. Medicine. 2025. https:\/\/doi.org\/10.1016\/j.mpmed.2025.04.013.","journal-title":"Medicine"},{"issue":"11","key":"1476_CR24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/ddg.14335","volume":"18","author":"M Br\u00fcggen","year":"2020","unstructured":"Br\u00fcggen M, Stingl G. Subcutaneous white adipose tissue: the deepest layer of the cutaneous immune barrier. JDDG: J der Deutschen Dermatologischen Gesellschaft. 2020;18(11):1225\u20137. https:\/\/doi.org\/10.1111\/ddg.14335.","journal-title":"JDDG: J der Deutschen Dermatologischen Gesellschaft"},{"issue":"10151","key":"1476_CR25","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf D, et al. Melanoma. Lancet. 2018;392(10151):971\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(18)31559-9.","journal-title":"Lancet"},{"issue":"6","key":"1476_CR26","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.gendis.2022.04.004","volume":"9","author":"W Wagstaff","year":"2022","unstructured":"Wagstaff W, et al. Melanoma: molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance. Genes Dis. 2022;9(6):1608\u201323. https:\/\/doi.org\/10.1016\/j.gendis.2022.04.004.","journal-title":"Genes Dis"},{"issue":"1","key":"1476_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.clindermatol.2025.01.015","volume":"43","author":"C Gronbeck","year":"2025","unstructured":"Gronbeck C, Kerr PE. Nodular melanoma. Clin Dermatol. 2025;43(1):64\u201370. https:\/\/doi.org\/10.1016\/j.clindermatol.2025.01.015.","journal-title":"Clin Dermatol"},{"key":"1476_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115356","volume":"220","author":"S Reinhard","year":"2025","unstructured":"Reinhard S, et al. First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: a multicenter study from the prospective skin cancer registry ADOREG. Eur J Cancer. 2025;220:115356. https:\/\/doi.org\/10.1016\/j.ejca.2025.115356.","journal-title":"Eur J Cancer"},{"key":"1476_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2025.110925","volume":"127","author":"SB Hashemi","year":"2025","unstructured":"Hashemi SB, Soltani S, Yousufzai S, Fatehi N, Yousefi A. Lentigo maligna melanoma of the face: clinical insights from a case of recurrence following surgical excision. Int J Surg Case Rep. 2025;127:110925. https:\/\/doi.org\/10.1016\/j.ijscr.2025.110925.","journal-title":"Int J Surg Case Rep"},{"key":"1476_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143535","author":"S Fernandes","year":"2022","unstructured":"Fernandes S, Vyas C, Lim P, Pereira RF, Vir\u00f3s A, B\u00e1rtolo P. 3D bioprinting: an enabling technology to understand melanoma. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14143535.","journal-title":"Cancers"},{"issue":"6","key":"1476_CR31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41568-023-00565-7","volume":"23","author":"PP Centeno","year":"2023","unstructured":"Centeno PP, Pavet V, Marais R. The journey from melanocytes to melanoma. Nat Rev Cancer. 2023;23(6):372\u201390. https:\/\/doi.org\/10.1038\/s41568-023-00565-7.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1476_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/genes12101543","volume":"12","author":"J Motwani","year":"2021","unstructured":"Motwani J, Eccles MR. Genetic and genomic pathways of melanoma development, invasion and metastasis. Genes. 2021;12(10):1543. https:\/\/doi.org\/10.3390\/genes12101543.","journal-title":"Genes"},{"issue":"2","key":"1476_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/cancers16020470","volume":"16","author":"Y Al Hmada","year":"2024","unstructured":"Al Hmada Y, et al. \u201cMechanisms of melanoma progression and treatment resistance: role of cancer stem-like cells. Cancers. 2024;16(2):470. https:\/\/doi.org\/10.3390\/cancers16020470.","journal-title":"Cancers"},{"key":"1476_CR34","doi-asserted-by":"publisher","first-page":"vi14","DOI":"10.1093\/annonc\/mdp256","volume":"20","author":"P Mohr","year":"2009","unstructured":"Mohr P, Eggermont AMM, Hauschild A, Buzaid A. Staging of cutaneous melanoma. Ann Oncol. 2009;20:vi14\u201321. https:\/\/doi.org\/10.1093\/annonc\/mdp256.","journal-title":"Ann Oncol"},{"issue":"1","key":"1476_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soc.2010.09.007","volume":"20","author":"PV Dickson","year":"2011","unstructured":"Dickson PV, Gershenwald JE. Staging and prognosis of cutaneous melanoma. Surg Oncol Clin N Am. 2011;20(1):1\u201317. https:\/\/doi.org\/10.1016\/j.soc.2010.09.007.","journal-title":"Surg Oncol Clin N Am"},{"key":"1476_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/ITT.S134842","volume":"7","author":"B Domingues","year":"2018","unstructured":"Domingues B, Lopes J, Soares P, Populo H. Melanoma treatment in review. Immunotargets Ther. 2018;7:35\u201349. https:\/\/doi.org\/10.2147\/ITT.S134842.","journal-title":"Immunotargets Ther"},{"key":"1476_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/563493","volume":"2012","author":"R Shimizu","year":"2012","unstructured":"Shimizu R, Kishi K. Skin graft. Plast Surg Int. 2012;2012:1\u20135. https:\/\/doi.org\/10.1155\/2012\/563493.","journal-title":"Plast Surg Int"},{"issue":"3","key":"1476_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3322\/caac.21224","volume":"64","author":"V Saranga-Perry","year":"2014","unstructured":"Saranga-Perry V, Ambe C, Zager JS, Kudchadkar RR. Recent developments in the medical and surgical treatment of melanoma. CA Cancer J Clin. 2014;64(3):171\u201385. https:\/\/doi.org\/10.3322\/caac.21224.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1476_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041106","volume":"15","author":"A Knight","year":"2023","unstructured":"Knight A, Karapetyan L, Kirkwood JM. Immunotherapy in melanoma: recent advances and future directions. Cancers. 2023;15(4):1106. https:\/\/doi.org\/10.3390\/cancers15041106.","journal-title":"Cancers"},{"issue":"23","key":"1476_CR40","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1056\/NEJMra2034861","volume":"384","author":"BD Curti","year":"2021","unstructured":"Curti BD, Faries MB. Recent advances in the treatment of melanoma. N Engl J Med. 2021;384(23):2229\u201340. https:\/\/doi.org\/10.1056\/NEJMra2034861.","journal-title":"N Engl J Med"},{"issue":"2","key":"1476_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020482","volume":"12","author":"H Patel","year":"2020","unstructured":"Patel H, et al. Current advances in the treatment of BRAF-mutant melanoma. Cancers. 2020;12(2):482. https:\/\/doi.org\/10.3390\/cancers12020482.","journal-title":"Cancers"},{"key":"1476_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104276","volume":"196","author":"A Boutros","year":"2024","unstructured":"Boutros A, et al. The treatment of advanced melanoma: current approaches and new challenges. Crit Rev Oncol Hematol. 2024;196:104276. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104276.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"1476_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126388","volume":"23","author":"A Villani","year":"2022","unstructured":"Villani A, Potestio L, Fabbrocini G, Troncone G, Malapelle U, Scalvenzi M. The treatment of advanced melanoma: therapeutic update. Int J Mol Sci. 2022;23(12):6388. https:\/\/doi.org\/10.3390\/ijms23126388.","journal-title":"Int J Mol Sci"},{"key":"1476_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1175503","author":"N Manduca","year":"2023","unstructured":"Manduca N, Maccafeo E, De Maria R, Sistigu A, Musella M. 3D cancer models: one step closer to in vitro human studies. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1175503.","journal-title":"Front Immunol"},{"issue":"1","key":"1476_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00887-3","volume":"12","author":"C Jubelin","year":"2022","unstructured":"Jubelin C, et al. Three-dimensional in vitro culture models in oncology research. Cell Biosci. 2022;12(1):155. https:\/\/doi.org\/10.1186\/s13578-022-00887-3.","journal-title":"Cell Biosci"},{"key":"1476_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2021.111914","volume":"122","author":"A Herreros-Pomares","year":"2021","unstructured":"Herreros-Pomares A, et al. 3D printing novel in vitro cancer cell culture model systems for lung cancer stem cell study. Mater Sci Eng C Mater Biol Appl. 2021;122:111914. https:\/\/doi.org\/10.1016\/j.msec.2021.111914.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"13","key":"1476_CR47","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.7150\/ijbs.96469","volume":"20","author":"A Esposito","year":"2024","unstructured":"Esposito A, Ferraresi A, Vallino L, Garavaglia B, Dhanasekaran DN, Isidoro C. Three-dimensional in vitro cell cultures as a feasible and promising alternative to two-dimensional and animal models in cancer research. Int J Biol Sci. 2024;20(13):5293\u2013311. https:\/\/doi.org\/10.7150\/ijbs.96469.","journal-title":"Int J Biol Sci"},{"key":"1476_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115295","volume":"208","author":"J Viegas","year":"2024","unstructured":"Viegas J, Sarmento B. Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research. Adv Drug Deliv Rev. 2024;208:115295. https:\/\/doi.org\/10.1016\/j.addr.2024.115295.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1476_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113207","volume":"417","author":"DA Monico","year":"2022","unstructured":"Monico DA, Calori IR, Souza C, Espreafico EM, Bi H, Tedesco AC. Melanoma spheroid-containing artificial dermis as an alternative approach to in vivo models. Exp Cell Res. 2022;417(1):113207. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113207.","journal-title":"Exp Cell Res"},{"key":"1476_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2025.107049","volume":"208","author":"S Wu","year":"2025","unstructured":"Wu S, Hatahet T, Al-Jamal WT. Enhancing the photothermal properties of indocyanine green in melanoma spheroids via encapsulation in Span 80-containing lipid nanocapsules. Eur J Pharm Sci. 2025;208:107049. https:\/\/doi.org\/10.1016\/j.ejps.2025.107049.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"1476_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26030717","volume":"26","author":"H Hundsberger","year":"2021","unstructured":"Hundsberger H, et al. Concentration-dependent pro- and antitumor activities of Quercetin in human melanoma spheroids: comparative analysis of 2D and 3D cell culture models. Molecules. 2021;26(3):717. https:\/\/doi.org\/10.3390\/molecules26030717.","journal-title":"Molecules"},{"issue":"4","key":"1476_CR52","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s12253-020-00837-9","volume":"26","author":"V Koroknai","year":"2020","unstructured":"Koroknai V, Patel V, Sz\u00e1sz I, \u00c1d\u00e1ny R, Balazs M. Gene expression signature of BRAF inhibitor resistant melanoma spheroids. Pathol Oncol Res. 2020;26(4):2557\u201366. https:\/\/doi.org\/10.1007\/s12253-020-00837-9.","journal-title":"Pathol Oncol Res"},{"key":"1476_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106323","volume":"182","author":"L Porcelli","year":"2022","unstructured":"Porcelli L, et al. BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy. Pharmacol Res. 2022;182:106323. https:\/\/doi.org\/10.1016\/j.phrs.2022.106323.","journal-title":"Pharmacol Res"},{"key":"1476_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202417226","author":"X Luo","year":"2025","unstructured":"Luo X, et al. Label-free 3D photoacoustic imaging of tumor organoids for volumetric drug screening. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202417226.","journal-title":"Adv Sci"},{"issue":"1","key":"1476_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19307-0","volume":"12","author":"A Leikeim","year":"2022","unstructured":"Leikeim A, et al. A preclinical model of cutaneous melanoma based on reconstructed human epidermis. Sci Rep. 2022;12(1):16269. https:\/\/doi.org\/10.1038\/s41598-022-19307-0.","journal-title":"Sci Rep"},{"issue":"14","key":"1476_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143535","volume":"14","author":"S Fernandes","year":"2022","unstructured":"Fernandes S, Vyas C, Lim P, Pereira RF, Vir\u00f3s A, B\u00e1rtolo P. 3D bioprinting: an enabling technology to understand melanoma. Cancers. 2022;14(14):3535. https:\/\/doi.org\/10.3390\/cancers14143535.","journal-title":"Cancers"},{"issue":"24","key":"1476_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245779","volume":"15","author":"G Nomdedeu-Sancho","year":"2023","unstructured":"Nomdedeu-Sancho G, et al. In vitro three-dimensional (3D) models for melanoma immunotherapy. Cancers. 2023;15(24):5779. https:\/\/doi.org\/10.3390\/cancers15245779.","journal-title":"Cancers"},{"issue":"10","key":"1476_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20475","volume":"9","author":"B-X Wu","year":"2023","unstructured":"Wu B-X, et al. Application of three-dimensional (3D) bioprinting in anti-cancer therapy. Heliyon. 2023;9(10):e20475. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20475.","journal-title":"Heliyon"},{"key":"1476_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bprint.2024.e00357","volume":"43","author":"SA Behera","year":"2024","unstructured":"Behera SA, Nanda B, Achary PGR. Recent advancements and challenges in 3D bioprinting for cancer applications. Bioprinting. 2024;43:e00357. https:\/\/doi.org\/10.1016\/j.bprint.2024.e00357.","journal-title":"Bioprinting"},{"key":"1476_CR60","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.bioactmat.2023.08.018","volume":"31","author":"A Aazmi","year":"2024","unstructured":"Aazmi A, et al. Biofabrication methods for reconstructing extracellular matrix mimetics. Bioact Mater. 2024;31:475\u201396. https:\/\/doi.org\/10.1016\/j.bioactmat.2023.08.018.","journal-title":"Bioact Mater"},{"key":"1476_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121881","volume":"291","author":"D Banerjee","year":"2022","unstructured":"Banerjee D, et al. Strategies for 3D bioprinting of spheroids: a comprehensive review. Biomaterials. 2022;291:121881. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121881.","journal-title":"Biomaterials"},{"issue":"2","key":"1476_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering8020027","volume":"8","author":"C Benwood","year":"2021","unstructured":"Benwood C, et al. Natural biomaterials and their use as bioinks for printing tissues. Bioengineering. 2021;8(2):27. https:\/\/doi.org\/10.3390\/bioengineering8020027.","journal-title":"Bioengineering"},{"key":"1476_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202107993","author":"R Schmid","year":"2022","unstructured":"Schmid R, et al. A new printable alginate\/hyaluronic acid\/gelatin hydrogel suitable for biofabrication of in vitro and in vivo metastatic melanoma models. Adv Funct Mater. 2022. https:\/\/doi.org\/10.1002\/adfm.202107993.","journal-title":"Adv Funct Mater"},{"key":"1476_CR64","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc5529","author":"L Ouyang","year":"2020","unstructured":"Ouyang L, et al. Expanding and optimizing 3D bioprinting capabilities using complementary network bioinks. Sci Adv. 2020. https:\/\/doi.org\/10.1126\/sciadv.abc5529.","journal-title":"Sci Adv"},{"key":"1476_CR65","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.actbio.2018.10.028","volume":"95","author":"M Shin","year":"2019","unstructured":"Shin M, Galarraga JH, Kwon MY, Lee H, Burdick JA. Gallol-derived ECM-mimetic adhesive bioinks exhibiting temporal shear-thinning and stabilization behavior. Acta Biomater. 2019;95:165\u201375. https:\/\/doi.org\/10.1016\/j.actbio.2018.10.028.","journal-title":"Acta Biomater"},{"key":"1476_CR66","doi-asserted-by":"publisher","DOI":"10.1063\/5.0061361","author":"RJA Moakes","year":"2021","unstructured":"Moakes RJA, et al. A suspended layer additive manufacturing approach to the bioprinting of tri-layered skin equivalents. APL Bioeng. 2021. https:\/\/doi.org\/10.1063\/5.0061361.","journal-title":"APL Bioeng"},{"key":"1476_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biomaterials.2018.03.040","volume":"168","author":"BS Kim","year":"2018","unstructured":"Kim BS, et al. 3D cell printing of in vitro stabilized skin model and in vivo pre-vascularized skin patch using tissue-specific extracellular matrix bioink: a step towards advanced skin tissue engineering. Biomaterials. 2018;168:38\u201353. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.03.040.","journal-title":"Biomaterials"},{"issue":"2","key":"1476_CR68","doi-asserted-by":"publisher","first-page":"025005","DOI":"10.1088\/1758-5090\/aa9e1e","volume":"10","author":"WL Ng","year":"2018","unstructured":"Ng WL, Qi JTZ, Yeong WY, Naing MW. Proof-of-concept: 3D bioprinting of pigmented human skin constructs. Biofabrication. 2018;10(2):025005. https:\/\/doi.org\/10.1088\/1758-5090\/aa9e1e.","journal-title":"Biofabrication"},{"key":"1476_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10324","author":"T Baltazar","year":"2023","unstructured":"Baltazar T, et al. 3D bioprinting of an implantable xeno-free vascularized human skin graft. Bioeng Transl Med. 2023. https:\/\/doi.org\/10.1002\/btm2.10324.","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"1476_CR70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/pcmr.12172","volume":"27","author":"RR Braeuer","year":"2014","unstructured":"Braeuer RR, et al. Why is melanoma so metastatic? Pigment Cell Melanoma Res. 2014;27(1):19\u201336. https:\/\/doi.org\/10.1111\/pcmr.12172.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1476_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00109","author":"Z Wei","year":"2020","unstructured":"Wei Z, et al. Two-dimensional cellular and three-dimensional bio-printed skin models to screen topical-use compounds for irritation potential. Front Bioeng Biotechnol. 2020. https:\/\/doi.org\/10.3389\/fbioe.2020.00109.","journal-title":"Front Bioeng Biotechnol"},{"issue":"62","key":"1476_CR72","doi-asserted-by":"publisher","first-page":"106132","DOI":"10.18632\/oncotarget.22190","volume":"8","author":"A Passarelli","year":"2017","unstructured":"Passarelli A, Mannavola F, Stucci LS, Tucci M, Silvestris F. Immune system and melanoma biology: a balance between immunosurveillance and immune escape. Oncotarget. 2017;8(62):106132\u201342. https:\/\/doi.org\/10.18632\/oncotarget.22190.","journal-title":"Oncotarget"},{"issue":"5","key":"1476_CR73","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/exd.13670","volume":"27","author":"A Marconi","year":"2018","unstructured":"Marconi A, Quadri M, Saltari A, Pincelli C. Progress in melanoma modelling in vitro. Exp Dermatol. 2018;27(5):578\u201386. https:\/\/doi.org\/10.1111\/exd.13670.","journal-title":"Exp Dermatol"},{"issue":"2","key":"1476_CR74","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/pcmr.13078","volume":"36","author":"LM Nascentes Melo","year":"2023","unstructured":"Nascentes Melo LM, et al. Advancements in melanoma cancer metastasis models. Pigment Cell Melanoma Res. 2023;36(2):206\u201323. https:\/\/doi.org\/10.1111\/pcmr.13078.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1476_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401136","author":"P V\u00e1zquez-Aristizabal","year":"2024","unstructured":"V\u00e1zquez-Aristizabal P, et al. Biofabrication and monitoring of a 3D printed skin model for melanoma. Adv Healthc Mater. 2024. https:\/\/doi.org\/10.1002\/adhm.202401136.","journal-title":"Adv Healthc Mater"},{"issue":"3","key":"1476_CR76","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/ac8dc6","volume":"15","author":"J L\u00f3pez de Andr\u00e9s","year":"2023","unstructured":"L\u00f3pez de Andr\u00e9s J, et al. Biofabrication of a tri-layered 3D-bioprinted CSC-based malignant melanoma model for personalized cancer treatment. Biofabrication. 2023;15(3):035016. https:\/\/doi.org\/10.1088\/1758-5090\/ac8dc6.","journal-title":"Biofabrication"},{"key":"1476_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136958","volume":"282","author":"MC Teixeira","year":"2024","unstructured":"Teixeira MC, et al. Biobased hydrogel bioinks of pectin, nanocellulose and lysozyme nanofibrils for the bioprinting of A375 melanoma cell-laden 3D in vitro platforms. Int J Biol Macromol. 2024;282:136958. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136958.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"1476_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030589","volume":"10","author":"Y-M Jeong","year":"2021","unstructured":"Jeong Y-M, et al. 3D-printed collagen scaffolds promote maintenance of cryopreserved patients-derived melanoma explants. Cells. 2021;10(3):589. https:\/\/doi.org\/10.3390\/cells10030589.","journal-title":"Cells"},{"issue":"4","key":"1476_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering9040166","volume":"9","author":"N Antunes","year":"2022","unstructured":"Antunes N, Kundu B, Kundu SC, Reis RL, Correlo V. In vitro cancer models: a closer look at limitations on translation. Bioengineering. 2022;9(4):166. https:\/\/doi.org\/10.3390\/bioengineering9040166.","journal-title":"Bioengineering"},{"issue":"1","key":"1476_CR80","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.drudis.2018.09.012","volume":"24","author":"A Parak","year":"2019","unstructured":"Parak A, Pradeep P, du Toit LC, Kumar P, Choonara YE, Pillay V. Functionalizing bioinks for 3D bioprinting applications. Drug Discov Today. 2019;24(1):198\u2013205. https:\/\/doi.org\/10.1016\/j.drudis.2018.09.012.","journal-title":"Drug Discov Today"},{"issue":"9","key":"1476_CR81","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1021\/acsbiomaterials.8b00399","volume":"4","author":"S Ding","year":"2018","unstructured":"Ding S, Feng L, Wu J, Zhu F, Tan Z, Yao R. Bioprinting of stem cells: interplay of bioprinting process, bioinks, and stem cell properties. ACS Biomater Sci Eng. 2018;4(9):3108\u201324. https:\/\/doi.org\/10.1021\/acsbiomaterials.8b00399.","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"1476_CR82","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/aaec52","volume":"11","author":"J Groll","year":"2018","unstructured":"Groll J, et al. A definition of bioinks and their distinction from biomaterial inks. Biofabrication. 2018;11(1):013001. https:\/\/doi.org\/10.1088\/1758-5090\/aaec52.","journal-title":"Biofabrication"},{"issue":"1","key":"1476_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63642-3","volume":"14","author":"R Schipka","year":"2024","unstructured":"Schipka R, et al. Characterization of two different alginate-based bioinks and the influence of melanoma growth within. Sci Rep. 2024;14(1):12945. https:\/\/doi.org\/10.1038\/s41598-024-63642-3.","journal-title":"Sci Rep"},{"issue":"7","key":"1476_CR84","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1021\/cr000108x","volume":"101","author":"KY Lee","year":"2001","unstructured":"Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev. 2001;101(7):1869\u201380. https:\/\/doi.org\/10.1021\/cr000108x.","journal-title":"Chem Rev"},{"issue":"6","key":"1476_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/polym12061237","volume":"12","author":"J Xu","year":"2020","unstructured":"Xu J, et al. Advances in the research of bioinks based on natural collagen, polysaccharide and their derivatives for skin 3D bioprinting. Polymers. 2020;12(6):1237. https:\/\/doi.org\/10.3390\/polym12061237.","journal-title":"Polymers"},{"issue":"14","key":"1476_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ma14143977","volume":"14","author":"J Naranda","year":"2021","unstructured":"Naranda J, Bra\u010di\u010d M, Vogrin M, Maver U. Recent advancements in 3D printing of polysaccharide hydrogels in cartilage tissue engineering. Materials. 2021;14(14):3977. https:\/\/doi.org\/10.3390\/ma14143977.","journal-title":"Materials"},{"key":"1476_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/polym8020042","author":"C Dong","year":"2016","unstructured":"Dong C, Lv Y. Application of collagen scaffold in tissue engineering: recent advances and new perspectives. Polymers. 2016. https:\/\/doi.org\/10.3390\/polym8020042.","journal-title":"Polymers"},{"key":"1476_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.medntd.2023.100211","volume":"17","author":"Z Li","year":"2023","unstructured":"Li Z, Ruan C, Niu X. Collagen-based bioinks for regenerative medicine: fabrication, application and prospective. Med Nov Technol Devices. 2023;17:100211. https:\/\/doi.org\/10.1016\/j.medntd.2023.100211.","journal-title":"Med Nov Technol Devices"},{"key":"1476_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202000097","author":"R Khoeini","year":"2021","unstructured":"Khoeini R, et al. Natural and synthetic bioinks for 3D bioprinting. Adv NanoBiomed Res. 2021. https:\/\/doi.org\/10.1002\/anbr.202000097.","journal-title":"Adv NanoBiomed Res"},{"issue":"1","key":"1476_CR90","doi-asserted-by":"publisher","first-page":"012009","DOI":"10.1088\/2631-7990\/ad878c","volume":"7","author":"ID Derman","year":"2025","unstructured":"Derman ID, et al. Advancements in 3D skin bioprinting: processes, bioinks, applications and sensor integration. Int J Extrem Manuf. 2025;7(1):012009. https:\/\/doi.org\/10.1088\/2631-7990\/ad878c.","journal-title":"Int J Extrem Manuf"},{"key":"1476_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2016.00012","author":"ME Katt","year":"2016","unstructured":"Katt ME, Placone AL, Wong AD, Xu ZS, Searson PC. In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform. Front Bioeng Biotechnol. 2016. https:\/\/doi.org\/10.3389\/fbioe.2016.00012.","journal-title":"Front Bioeng Biotechnol"},{"issue":"8","key":"1476_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/polym12081717","volume":"12","author":"Z Xie","year":"2020","unstructured":"Xie Z, Gao M, Lobo AO, Webster TJ. 3D bioprinting in tissue engineering for medical applications: the classic and the hybrid. Polymers. 2020;12(8):1717. https:\/\/doi.org\/10.3390\/polym12081717.","journal-title":"Polymers"},{"issue":"27","key":"1476_CR93","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1039\/D1TB00172H","volume":"9","author":"B Tan","year":"2021","unstructured":"Tan B, Gan S, Wang X, Liu W, Li X. Applications of 3D bioprinting in tissue engineering: advantages, deficiencies, improvements, and future perspectives. J Mater Chem B. 2021;9(27):5385\u2013413. https:\/\/doi.org\/10.1039\/D1TB00172H.","journal-title":"J Mater Chem B"},{"key":"1476_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2024.112853","volume":"240","author":"M Mirshafiei","year":"2024","unstructured":"Mirshafiei M, Rashedi H, Yazdian F, Rahdar A, Baino F. Advancements in tissue and organ 3D bioprinting: current techniques, applications, and future perspectives. Mater Des. 2024;240:112853. https:\/\/doi.org\/10.1016\/j.matdes.2024.112853.","journal-title":"Mater Des"},{"issue":"3","key":"1476_CR95","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/8\/3\/032002","volume":"8","author":"K H\u00f6lzl","year":"2016","unstructured":"H\u00f6lzl K, Lin S, Tytgat L, Van Vlierberghe S, Gu L, Ovsianikov A. Bioink properties before, during and after 3D bioprinting. Biofabrication. 2016;8(3):032002. https:\/\/doi.org\/10.1088\/1758-5090\/8\/3\/032002.","journal-title":"Biofabrication"},{"key":"1476_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.engreg.2020.12.001","volume":"2","author":"S Vanaei","year":"2021","unstructured":"Vanaei S, Parizi MS, Vanaei S, Salemizadehparizi F, Vanaei HR. An overview on materials and techniques in 3D bioprinting toward biomedical application. Engineered Regeneration. 2021;2:1\u201318. https:\/\/doi.org\/10.1016\/j.engreg.2020.12.001.","journal-title":"Engineered Regeneration"},{"issue":"5","key":"1476_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2022.107819","volume":"34","author":"W Sun","year":"2023","unstructured":"Sun W, et al. 3D skin models along with skin-on-a-chip systems: a critical review. Chin Chem Lett. 2023;34(5):107819. https:\/\/doi.org\/10.1016\/j.cclet.2022.107819.","journal-title":"Chin Chem Lett"},{"issue":"22","key":"1476_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212549","volume":"22","author":"NW Nkune","year":"2021","unstructured":"Nkune NW, Abrahamse H. Nanoparticle-based drug delivery systems for photodynamic therapy of metastatic melanoma: a review. Int J Mol Sci. 2021;22(22):12549. https:\/\/doi.org\/10.3390\/ijms222212549.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1476_CR99","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.det.2014.03.009","volume":"32","author":"AM Rkein","year":"2014","unstructured":"Rkein AM, Ozog DM. Photodynamic therapy. Dermatol Clin. 2014;32(3):415\u201325. https:\/\/doi.org\/10.1016\/j.det.2014.03.009.","journal-title":"Dermatol Clin"},{"key":"1476_CR100","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S134842","author":"B Domingues","year":"2018","unstructured":"Domingues B, Lopes JM, Soares P, P\u00f3pulo H, Dove Medical Press Ltd. Melanoma treatment in review. Immunotargets Ther. 2018. https:\/\/doi.org\/10.2147\/ITT.S134842.","journal-title":"Immunotargets Ther"},{"issue":"8","key":"1476_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082124","volume":"15","author":"AM Udrea","year":"2023","unstructured":"Udrea AM, et al. Photosensitizers-loaded nanocarriers for enhancement of photodynamic therapy in melanoma treatment. Pharmaceutics. 2023;15(8):2124. https:\/\/doi.org\/10.3390\/pharmaceutics15082124.","journal-title":"Pharmaceutics"},{"key":"1476_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189726","author":"B Mkhobongo","year":"2021","unstructured":"Mkhobongo B, Chandran R, Abrahamse H. The role of melanoma cell-derived exosomes (Mtex) and photodynamic therapy (pdt) within a tumor microenvironment. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22189726.","journal-title":"Int J Mol Sci"},{"key":"1476_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2023.103792","author":"AH Soliman","year":"2023","unstructured":"Soliman AH, Youness RA, Sebak AA, Handoussa H. Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19\/iNOS\/PD-L1 axis. Photodiagnosis Photodyn Ther. 2023. https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103792.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"1476_CR104","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.0c01322","author":"E Jung","year":"2021","unstructured":"Jung E, et al. Phenylthiourea-conjugated BODIPY as an efficient photosensitizer for tyrosinase-positive melanoma-targeted photodynamic therapy. ACS Appl Bio Mater. 2021. https:\/\/doi.org\/10.1021\/acsabm.0c01322.","journal-title":"ACS Appl Bio Mater"},{"key":"1476_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117063","author":"M Mu\u0161kovi\u0107","year":"2025","unstructured":"Mu\u0161kovi\u0107 M, Lon\u010dari\u0107 M, Ratkaj I, Malatesti N. Impact of the hydrophilic-lipophilic balance of free-base and Zn(II) tricationic pyridiniumporphyrins and irradiation wavelength in PDT against the melanoma cell lines. Eur J Med Chem. 2025. https:\/\/doi.org\/10.1016\/j.ejmech.2024.117063.","journal-title":"Eur J Med Chem"},{"key":"1476_CR106","doi-asserted-by":"publisher","DOI":"10.7150\/THNO.54227","author":"T Hu","year":"2021","unstructured":"Hu T, Wang Z, Shen W, Liang R, Yan D, Wei M. Recent advances in innovative strategies for enhanced cancer photodynamic therapy. Theranostics. 2021. https:\/\/doi.org\/10.7150\/THNO.54227.","journal-title":"Theranostics"},{"key":"1476_CR107","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jphotobiol.2018.11.019","volume":"190","author":"FAP de Morais","year":"2019","unstructured":"de Morais FAP, et al. Hypericin photodynamic activity in DPPC liposome. Part I: biomimetism of loading, location, interactions and thermodynamic properties. J Photochem Photobiol B. 2019;190:118\u201327. https:\/\/doi.org\/10.1016\/j.jphotobiol.2018.11.019.","journal-title":"J Photochem Photobiol B"},{"issue":"5","key":"1476_CR108","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1039\/c9pp00284g","volume":"19","author":"FAP De Morais","year":"2020","unstructured":"De Morais FAP, et al. Hypericin photodynamic activity in DPPC liposomes-part II: Stability and application in melanoma B16\u2013F10 cancer cells. Photochem Photobiol Sci. 2020;19(5):620\u201330. https:\/\/doi.org\/10.1039\/c9pp00284g.","journal-title":"Photochem Photobiol Sci"},{"issue":"4","key":"1476_CR109","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s42242-022-00202-6","volume":"5","author":"HL Ma","year":"2022","unstructured":"Ma HL, et al. In vitro 3D malignant melanoma model for the evaluation of hypericin-loaded oil-in-water microemulsion in photodynamic therapy. Bio-Design and Manuf. 2022;5(4):660\u201373. https:\/\/doi.org\/10.1007\/s42242-022-00202-6.","journal-title":"Bio-Design and Manuf"},{"issue":"45","key":"1476_CR110","doi-asserted-by":"publisher","first-page":"41829","DOI":"10.1021\/acsami.9b09560","volume":"11","author":"S Wang","year":"2019","unstructured":"Wang S, et al. Chlorin-based photoactivable Galectin-3-inhibitor nanoliposome for enhanced photodynamic therapy and NK cell-related immunity in melanoma. ACS Appl Mater Interfaces. 2019;11(45):41829\u201341. https:\/\/doi.org\/10.1021\/acsami.9b09560.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"11","key":"1476_CR111","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1021\/acs.molpharmaceut.3c00494","volume":"20","author":"A Gaballo","year":"2023","unstructured":"Gaballo A, et al. Enhanced delivery of 5-Aminolevulinic Acid by lecithin invasomes in 3D melanoma cancer model. Mol Pharm. 2023;20(11):5593\u2013606. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00494.","journal-title":"Mol Pharm"},{"issue":"1","key":"1476_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/biom13010055","volume":"13","author":"MS Kang","year":"2022","unstructured":"Kang MS, et al. Advances and innovations of 3D bioprinting skin. Biomolecules. 2022;13(1):55. https:\/\/doi.org\/10.3390\/biom13010055.","journal-title":"Biomolecules"},{"issue":"1","key":"1476_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84384-6","volume":"11","author":"R Taymour","year":"2021","unstructured":"Taymour R, Kilian D, Ahlfeld T, Gelinsky M, Lode A. 3D bioprinting of hepatocytes: core\u2013shell structured co-cultures with fibroblasts for enhanced functionality. Sci Rep. 2021;11(1):5130. https:\/\/doi.org\/10.1038\/s41598-021-84384-6.","journal-title":"Sci Rep"},{"issue":"11","key":"1476_CR114","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1089\/pho.2017.4308","volume":"35","author":"H Abrahamse","year":"2017","unstructured":"Abrahamse H, Kruger CA, Kadanyo S, Mishra A. Nanoparticles for advanced photodynamic therapy of cancer. Photomed Laser Surg. 2017;35(11):581\u20138. https:\/\/doi.org\/10.1089\/pho.2017.4308.","journal-title":"Photomed Laser Surg"},{"issue":"3","key":"1476_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21030342","volume":"21","author":"G Calixto","year":"2016","unstructured":"Calixto G, Bernegossi J, De Freitas L, Fontana C, Chorilli M. Nanotechnology-based drug delivery systems for photodynamic therapy of cancer: a review. Molecules. 2016;21(3):342. https:\/\/doi.org\/10.3390\/molecules21030342.","journal-title":"Molecules"},{"issue":"5","key":"1476_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2021.103120","volume":"14","author":"S Nazir","year":"2021","unstructured":"Nazir S, Khan MUA, Al-Arjan WS, Razak SIA, Javed A, Kadir MRA. Nanocomposite hydrogels for melanoma skin cancer care and treatment: in-vitro drug delivery, drug release kinetics and anti-cancer activities. Arab J Chem. 2021;14(5):103120. https:\/\/doi.org\/10.1016\/j.arabjc.2021.103120.","journal-title":"Arab J Chem"},{"key":"1476_CR117","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jconrel.2017.11.049","volume":"270","author":"VK Rai","year":"2018","unstructured":"Rai VK, Mishra N, Yadav KS, Yadav NP. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications. J Control Release. 2018;270:203\u201325. https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.049.","journal-title":"J Control Release"},{"key":"1476_CR118","doi-asserted-by":"publisher","unstructured":"I. Theochari, A. Xenakis, and V. Papadimitriou, Nanocarriers for effective drug delivery in Smart Nanocontainers, Elsevier. 2020. pp. 315\u2013341. https:\/\/doi.org\/10.1016\/B978-0-12-816770-0.00019-","DOI":"10.1016\/B978-0-12-816770-0.00019-"},{"key":"1476_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119744","volume":"232","author":"V Brancato","year":"2020","unstructured":"Brancato V, Oliveira JM, Correlo VM, Reis RL, Kundu SC. Could 3D models of cancer enhance drug screening? Biomaterials. 2020;232:119744. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119744.","journal-title":"Biomaterials"},{"key":"1476_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00514-w","author":"L Neufeld","year":"2022","unstructured":"Neufeld L, Yeini E, Pozzi S, Satchi-Fainaro R. 3D bioprinted cancer models: from basic biology to drug development. Nat Rev Cancer. 2022. https:\/\/doi.org\/10.1038\/s41568-022-00514-w.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1476_CR121","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/cancers14010190","volume":"14","author":"MA Barbosa","year":"2021","unstructured":"Barbosa MA, Xavier CP, Pereira RF, Petrikait\u0117 V, Vasconcelos MH. 3D cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs. Cancers. 2021;14(1):190. https:\/\/doi.org\/10.3390\/cancers14010190.","journal-title":"Cancers"},{"key":"1476_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1162905","author":"RM Visalakshan","year":"2023","unstructured":"Visalakshan RM, et al. Opportunities and challenges to engineer 3D models of tumor-adaptive immune interactions. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1162905.","journal-title":"Front Immunol"},{"issue":"12","key":"1476_CR123","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.tibtech.2024.06.008","volume":"42","author":"IL Co","year":"2024","unstructured":"Co IL, Fomina A, Nurse M, McGuigan AP. Applications and evolution of 3D cancer-immune cell models. Trends Biotechnol. 2024;42(12):1615\u201327. https:\/\/doi.org\/10.1016\/j.tibtech.2024.06.008.","journal-title":"Trends Biotechnol"},{"key":"1476_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245779","author":"G Nomdedeu-Sancho","year":"2023","unstructured":"Nomdedeu-Sancho G, et al. In vitro three-dimensional (3D) models for melanoma immunotherapy. Cancers. 2023. https:\/\/doi.org\/10.3390\/cancers15245779.","journal-title":"Cancers"},{"key":"1476_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121639","volume":"287","author":"P Jain","year":"2022","unstructured":"Jain P, Kathuria H, Dubey N. Advances in 3D bioprinting of tissues\/organs for regenerative medicine and in-vitro models. Biomaterials. 2022;287:121639. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121639.","journal-title":"Biomaterials"},{"key":"1476_CR126","doi-asserted-by":"publisher","DOI":"10.2217\/3dp-2022-0026","author":"S Vijayavenkataraman","year":"2023","unstructured":"Vijayavenkataraman S. 3D bioprinting: challenges in commercialization and clinical translation. J 3D Print Med. 2023. https:\/\/doi.org\/10.2217\/3dp-2022-0026.","journal-title":"J 3D Print Med"},{"key":"1476_CR127","unstructured":"U.S. Food and Drug Administration (FDA), Predictive toxicology roadmap 2017."},{"key":"1476_CR128","unstructured":"U.S. Food and Drug Administration (FDA), Potential approaches to drive future integration of new alternative methods for regulatory decision-making 2024."},{"issue":"11","key":"1476_CR129","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1039\/D3BM00159H","volume":"11","author":"X Mi","year":"2023","unstructured":"Mi X, et al. 3D bioprinting tumor models mimic the tumor microenvironment for drug screening. Biomater Sci. 2023;11(11):3813\u201327. https:\/\/doi.org\/10.1039\/D3BM00159H.","journal-title":"Biomater Sci"},{"key":"1476_CR130","doi-asserted-by":"publisher","DOI":"10.1177\/20417314231187113","author":"S Liu","year":"2023","unstructured":"Liu S, et al. 3D bioprinting tissue analogs: current development and translational implications. J Tissue Eng. 2023. https:\/\/doi.org\/10.1177\/20417314231187113.","journal-title":"J Tissue Eng"},{"key":"1476_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119536","volume":"226","author":"I Matai","year":"2020","unstructured":"Matai I, Kaur G, Seyedsalehi A, McClinton A, Laurencin CT. Progress in 3D bioprinting technology for tissue\/organ regenerative engineering. Biomaterials. 2020;226:119536. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119536.","journal-title":"Biomaterials"}],"container-title":["BioMedical Engineering OnLine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-025-01476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12938-025-01476-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-025-01476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:05:44Z","timestamp":1762430744000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomedical-engineering-online.biomedcentral.com\/articles\/10.1186\/s12938-025-01476-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":131,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1476"],"URL":"https:\/\/doi.org\/10.1186\/s12938-025-01476-4","relation":{},"ISSN":["1475-925X"],"issn-type":[{"value":"1475-925X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}